Gastrointestinal Tumors, Also Known As GI Tumors, Are Abnormal Growths Of Cells In The Digestive System. These Tumors Can Be Benign (Noncancerous) Or Malignant (Cancerous). Benign Tumors Include Polyps And Lipomas, While Malignant Tumors Include Adenocarcinomas And Sarcomas. GI Tumors Can Occur In Any Part Of The Digestive System, Including The Esophagus, Stomach, Small Intestine, Large Intestine, Rectum, And Anus. Risk Factors For Gastrointestinal Tumors Include Age, Gender, Ethnicity, Family History Of GI Cancer, Smoking, And Alcohol Use. Other Risk Factors May Include Inherited Genetic Mutations, Certain Chronic Diseases, And A History Of Radiation Exposure. Symptoms Of Gastrointestinal Tumors May Include Abdominal Pain, Changes In Bowel Habits, Nausea, Vomiting, Weight Loss, A Feeling Of Fullness After Eating, And Weakness. Diagnostic Tests For GI Tumors May Include An Endoscopy, Blood Tests, Biopsy, Imaging Tests, And Genetic Testing. Treatment For GI Tumors Depends On The Type, Size, And Location Of The Tumor, As Well As The Patient’s Overall Health And Individual Preferences.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy